X4 Pharmaceuticals, Inc.
A biopharmaceutical company focused on researching, developing and commercializing novel therapeutics for the treatment of rare diseases. Its lead product candidate, mavorixafor, is a once-daily oral treatment with potential to treat a variety of diseases, including WHIM syndrome, primary immunodeficiencies and certain types of cancer.
Overview
Overview | |
|---|---|
Country | United States |
State | Massachusetts |
Employees | 116 |
Founded | 2014 |
Financials | |
|---|---|
Market Capitalization | 117.91M |
Revenue | |
Operating Income | -115.71M |
Operating Margin | |
Net Income | -128.91M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4852 / 5373 |
Sector : Healthcare | 917 / 1144 |
Industry : Biotechnology | 476 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 3974 / 5565 |
Sector : Healthcare | 681 / 1182 |
Industry : Biotechnology | 360 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4907 / 5436 |
Sector : Healthcare | 959 / 1164 |
Industry : Biotechnology | 517 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3912 / 5330 |
Sector : Healthcare | 597 / 1174 |
Industry : Biotechnology | 232 / 667 |